Bruder Healthcare Company, LLC

Established in 1986 and based in Alpharetta, Georgia, Bruder Healthcare Company develops innovative eye care solutions, focusing on products that alleviate ocular health issues such as dry eye and blepharitis. Bruder Healthcare Company specializes in eye care solutions aimed at addressing various ocular health concerns. Founded by Mark Bruder, the company has been operational since 1986 and is located in Alpharetta, Georgia, US. Bruder has executed 2 deals to date, with the most recent transaction being an acquisition by Greybrook Capital, the financial terms of which are not disclosed.

Bruder Healthcare Company specializes in innovative eye care solutions designed to address various ocular health concerns, particularly dry eye, blepharitis, and other related conditions. The company’s core offerings include the Bruder Moist Heat Eye Compress, which utilizes patented MediBeads® technology to provide consistent and effective moist heat therapy for eye comfort. This mask is air-activated and can be used anywhere, making it accessible for individuals seeking relief from dry eyes or discomfort due to environmental factors. Another key product is The Dry Eye Drink™, formulated to support eye health through hyper-hydration, available in multiple flavors tailored to consumer preferences.

These products are aimed at both healthcare professionals and end-users, particularly individuals suffering from chronic eye conditions, and are available in markets including the United States, Canada, and various regions in Europe. Bruder Healthcare generates revenue through direct sales of its eye care products to consumers and healthcare professionals, along with partnerships with retailers and wholesalers. The transaction structure typically involves one-time purchases of individual products, such as the Bruder Moist Heat Eye Compress and The Dry Eye Drink™, which are positioned as premium therapeutic solutions for eye health. Specific pricing structures for these products are established to reflect their quality and effectiveness, focusing on providing value to customers.

The company’s sales strategy includes B2B transactions with medical professionals, who recommend Bruder products to their patients, thus facilitating a direct connection between the brand and its end-users. Through these channels, Bruder Healthcare maintains a steady stream of revenue derived from a combination of consumer demand and healthcare endorsements. Bruder Healthcare plans to develop and launch new products designed to enhance eye health in the coming years, although specific release dates are not disclosed. The company aims to expand its market presence into new regions, particularly targeting increased sales in Canada and Europe by 2025.

Recent funding from the acquisition by Greybrook Capital will be utilized to support these initiatives, enabling Bruder to enhance its product offerings and broaden its market reach.